File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Helicobacter pylori and probiotics

TitleHelicobacter pylori and probiotics
Authors
KeywordsHelicobacter pylori (probiotics and antibiotic treatment)
Issue Date2006
Citation
Milchwissenschaft, 2006, v. 61 n. 3, p. 273-277 How to Cite?
AbstractHelicobacter pylori was first isolated in 1982 and has since been recognized as a major cause of gastric inflammation and ulceration, as well as gastric cancer. Its ability to survive the extremely hostile environment offered by the stomach has been instrumental in its success as a pathogen. One-week triple therapy is currently used to eradicate the organisms, but there are several side effects associated with the treatment. Probiotic organisms produce several antimicrobial substances and have shown inhibitory activity towards this pathogen. Clinical trials though consistent with the in vitro data have proven unsuccessful in complete eradication of H. pylori from patients. Probiotic organisms helped relieve symptoms associated with the antibiotic therapy. The mechanism of action of these 'live feed supplements' needs to be elucidated.
Persistent Identifierhttp://hdl.handle.net/10722/144433
ISSN
2014 Impact Factor: 0.247
2015 SCImago Journal Rankings: 0.200
References

 

DC FieldValueLanguage
dc.contributor.authorHarnal, Sen_HK
dc.contributor.authorShah, NPen_HK
dc.date.accessioned2012-01-20T09:02:03Z-
dc.date.available2012-01-20T09:02:03Z-
dc.date.issued2006en_HK
dc.identifier.citationMilchwissenschaft, 2006, v. 61 n. 3, p. 273-277en_HK
dc.identifier.issn0026-3788en_HK
dc.identifier.urihttp://hdl.handle.net/10722/144433-
dc.description.abstractHelicobacter pylori was first isolated in 1982 and has since been recognized as a major cause of gastric inflammation and ulceration, as well as gastric cancer. Its ability to survive the extremely hostile environment offered by the stomach has been instrumental in its success as a pathogen. One-week triple therapy is currently used to eradicate the organisms, but there are several side effects associated with the treatment. Probiotic organisms produce several antimicrobial substances and have shown inhibitory activity towards this pathogen. Clinical trials though consistent with the in vitro data have proven unsuccessful in complete eradication of H. pylori from patients. Probiotic organisms helped relieve symptoms associated with the antibiotic therapy. The mechanism of action of these 'live feed supplements' needs to be elucidated.en_HK
dc.languageengen_US
dc.relation.ispartofMilchwissenschaften_HK
dc.subjectHelicobacter pylori (probiotics and antibiotic treatment)en_HK
dc.titleHelicobacter pylori and probioticsen_HK
dc.typeArticleen_HK
dc.identifier.emailShah, NP: npshah@hku.hken_HK
dc.identifier.authorityShah, NP=rp01571en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-33745965914en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33745965914&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume61en_HK
dc.identifier.issue3en_HK
dc.identifier.spage273en_HK
dc.identifier.epage277en_HK
dc.identifier.scopusauthoridHarnal, S=14039153200en_HK
dc.identifier.scopusauthoridShah, NP=7401823907en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats